SCENESSE
Clinuvel Pharmaceuticals Limited
Application Filed: 2018-02-13
Trademark Application Details
REGISTERED
| Research |
OneLook
Acronym Finder
|
| Serial Number | 79229902 |
| Registration Number | 5724241 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Attorney Name | Michelle P. Ciotola |
| Attorney Docket Number | SCF0009TUS |
| Law Office Assigned | N50 |
| Employee Name | HOPKINS, SARAH COLLEEN |
Timeline
| 2018-02-13 | Application Filed |
| 2019-01-29 | Published for Opposition |
| 2019-04-16 | Location: PUBLICATION AND ISSUE SECTION |
| 2019-04-16 | Status: Live/Registered |
| 2019-04-16 | Trademark Registered |
| 2019-11-14 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Clinuvel Pharmaceuticals Limited |
| Entity Statement | Limited Company |
| Address | Level 11, 535 Bourke Street Melbourne VIC 3000 AU |
| Legal Entity Type | |
| Legal Entity State | AU |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 3 |
| U.S. Codes: | 001,004,006,050,051,052 |
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0031 | Cosmetic preparations for skin care, based on analogues of melanocyte-stimulating hormone (MSH), in particular afamelanotide; non-medicated sun tanning preparations based on analogues of melanocyte-stimulating hormone (MSH), in particular afamelanotide; cosmetics for tanning the skin, namely, cosmetics for tanning the skin based on analogues of melanocyte-stimulating hormone (MSH), in particular afamelanotide, and preparations for tanning without sunlight based on analogues of melanocyte-stimulating hormone (MSH), in particular afamelanotide |
| GS0031 | Cosmetic preparations for skin care, based on analogues of melanocyte-stimulating hormone (MSH), in particular afamelanotide; non-medicated sun tanning preparations based on analogues of melanocyte-stimulating hormone (MSH), in particular afamelanotide; cosmetics for tanning the skin, namely, cosmetics for tanning the skin based on analogues of melanocyte-stimulating hormone (MSH), in particular afamelanotide, and preparations for tanning without sunlight based on analogues of melanocyte-stimulating hormone (MSH), in particular afamelanotide |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB | 2018-04-05 | 1 SDRC M: |
| LIMITATION FROM ORIGINAL APPLICATION ENTERED | 2018-04-09 | 2 LIMI I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2018-04-10 | 3 NWOS I:Incoming Correspondence |
| APPLICATION FILING RECEIPT MAILED | 2018-04-14 | 4 MAFR O:Outgoing Correspondence |
| ASSIGNED TO EXAMINER | 2018-05-29 | 5 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2018-05-31 | 6 CNRT R:Renewal |
| NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | 2018-06-01 | 7 RFCR E:E-Mail |
| REFUSAL PROCESSED BY MPU | 2018-06-07 | 8 RFRR P: |
| NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | 2018-06-07 | 9 RFCS P: |
| REFUSAL PROCESSED BY IB | 2018-06-29 | 10 RFNT P: |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2018-12-03 | 11 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2018-12-03 | 12 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2018-12-04 | 13 TEME I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2018-12-05 | 14 CNSA O:Outgoing Correspondence |
| ASSIGNED TO LIE | 2018-12-26 | 15 ALIE A:Allowance for Publication |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2019-01-09 | 16 NONP E:E-Mail |
| NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | 2019-01-09 | 17 OP2R P: |
| NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | 2019-01-09 | 18 OPNS P: |
| TOTAL INVALIDATION PROCESSED BY THE IB | 2019-01-11 | 19 INNT P: |
| PUBLISHED FOR OPPOSITION | 2019-01-29 | 20 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2019-01-29 | 21 NPUB E:E-Mail |
| NOTIFICATION PROCESSED BY IB | 2019-03-01 | 22 GPNX P: |
| REGISTERED-PRINCIPAL REGISTER | 2019-04-16 | 23 R.PR A:Allowance for Publication |
| FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | 2019-07-16 | 24 FICR P: |
| FINAL DISPOSITION PROCESSED | 2019-08-08 | 25 FIMP P: |
| FINAL DISPOSITION NOTICE SENT TO IB | 2019-08-08 | 26 FICS P: |
| FINAL DECISION TRANSACTION PROCESSED BY IB | 2019-09-13 | 27 FINO P: |
| CHANGE OF NAME/ADDRESS REC'D FROM IB | 2019-11-14 | 28 ADCH M: |
| INTERNATIONAL REGISTRATION RENEWED | 2020-07-02 | 29 RNWL P: |
| COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | 2024-04-16 | 30 REM3 E:E-Mail |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 SCENESSE 79229902 5724241 Live/Registered |
Clinuvel Pharmaceuticals Limited 2018-02-13 |
 SCENESSE 79088813 4008201 Dead/Cancelled |
Clinuvel Pharmaceuticals Limited 2010-05-10 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 